Wealth Preservation Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Wealth Preservation Advisors's BMY Position: Q2 2026 in Review
Wealth Preservation Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 2,543 shares — an estimated $154K sold.
Wealth Preservation Advisors first reported a position in BMY in Q1 2025 and held it in 5 quarters. The position peaked at $154K in Q1 2026. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Wealth Preservation Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
- Wealth Preservation Advisors sold 2,543 Bristol-Myers Squibb shares in Q2 2026, an estimated $154K.
- Wealth Preservation Advisors first reported a position in Bristol-Myers Squibb in Q1 2025 and held it in 5 quarters.
- Wealth Preservation Advisors's Bristol-Myers Squibb position peaked at $154K in Q1 2026.
- 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Wealth Preservation Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.